Correction
Accepted on 17 Jul 2025
Correction: Understanding the role of the gut microbiome in gastrointestinal cancer: A review
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1662597
Type at least 3 characters
1,211 articles
Original Research
Accepted on 17 Jul 2025
A pharmacovigilance study of the association between linaclotide/plecanatide and muscle spasms based on Food and Drug Administration adverse event reporting system
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1635792
- 110 views
Correction
Accepted on 16 Jul 2025
A Pathology-Attention Multi-Instance Learning Framework for Multimodal Classification of Colorectal Lesions
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1666330
Original Research
Published on 16 Jul 2025
Analyzing the potential targets and mechanisms of liver damage induced by acetyl tributyl citrate plasticizer using network toxicology, molecular docking and in vitro experiments
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1636576
- 298 views
Study Protocol
Accepted on 11 Jul 2025
Brucea javanica Oil Emulsion plus Supportive Care for Refractory Advanced Colorectal Cancer: A Pilot RCT Protocol
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1610575
- 236 views
Systematic Review
Accepted on 11 Jul 2025
Potential of ciprofol as an alternative to propofol in elderly patients undergoing gastrointestinal endoscopy: a meta-analysis and trial sequential analysis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1644182
- 130 views
Original Research
Accepted on 11 Jul 2025
Exploring the Molecular Characteristics of Inflammatory Bowel Disease from the Perspective of Hypoxia-Related Genes
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1612676
Review
Published on 11 Jul 2025
Beyond antibiotics: probiotics as a promising ally against Helicobacter pylori
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1620870
- 1,511 views
Original Research
Published on 11 Jul 2025
Evaluating the risk of osteoporosis-related adverse events with proton pump inhibitors: a pharmacovigilance study
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1582908
- 309 views
Review
Published on 11 Jul 2025
Role of the Annexin A protein family in liver diseases: insights and therapeutic opportunities
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1569927
- 318 views
Systematic Review
Published on 11 Jul 2025
What is the optimal biological therapy for moderate to severe ulcerative colitis: a systematic review and network meta-analysis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1602024
- 1,006 views
Original Research
Published on 09 Jul 2025
D-glucaro-1,4-lactone alleviates acetaminophen-induced hepatotoxicity in mice via modulating gut microbiota and metabolites associated with Lactobacillus–glutamine and nicotinic acid pathways
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1627850
- 366 views
Original Research
Published on 08 Jul 2025
Glucagon-like peptide-1 receptor agonist-induced cholecystitis and cholelithiasis: a real-world pharmacovigilance analysis using the FAERS database
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1557691
- 481 views
Original Research
Accepted on 04 Jul 2025
Hydrogen gas (H2) delivered by intraperitoneal injection alleviated methionine-and choline-deficient diet-induced metabolic dysfunctionassociated steatotic liver disease in mice via inhibiting GSDMD-and GSDME-mediated pyroptosis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1575106
- 198 views
Review
Accepted on 02 Jul 2025
The role of gallic acid in liver disease: A review of its phytochemistry, pharmacology, and safety
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1595508
- 147 views
Original Research
Published on 02 Jul 2025
Nimotuzumab plus chemotherapy and immunotherapy as first-line/neoadjuvant therapy for advanced esophageal squamous cell carcinoma
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1585048
- 777 views